Atlantia Clinical Trials is pleased to announce the appointment of Dr. Nontokozo Felicity Yusuff as the new Study Doctor, marking an exciting beginning to 2025 with multiple clinical studies underway, including women’s health-focused research.
Dr. Yusuff brings a wealth of experience in both general medical practice and clinical research, making her a valuable asset for international sponsors. Her extensive clinical expertise spans diverse patient groups, including pediatrics, geriatrics, and general adult medicine, with additional experience in gynecology and performing minor surgical procedures.
In addition to her clinical practice, Dr. Yusuff has excelled as a Principal Investigator and Sub-Investigator on global clinical trials across multiple therapeutic areas, including vaccine research and non-alcoholic steatohepatitis (NASH). She has been successfully and actively involved in preparing for and supporting regulatory inspections, including audits by the FDA and South African Health Products Regulatory Authority (SAHPRA), ensuring the delivery of high-quality data and compliance.
“Dr. Yusuff’s broad clinical expertise and proven research leadership make her an excellent addition to Atlantia Clinical Trials,” said Barry Skillington, Chief Commercial Officer at Atlantia Clinical Trials. “Her experience working with diverse patient groups and her ability to navigate regulatory complexities will support sponsors in achieving success in European and American markets.”
Dr. Yusuff is an IMC-registered medical professional certified in Good Clinical Practice (ICH-GCP) and Advanced Cardiac Life Support (ACLS). She also brings valuable experience in managing recruitment teams for high-pressure studies, preparing sites for inspections, and driving operational excellence.
“I am excited to bring my clinical and research experience to Atlantia Clinical Trials and contribute to advancing health outcomes,” said Dr. Yusuff. “Collaborating with a talented team on impactful, patient-focused studies aligns with my passion for delivering high-quality research.”
Atlantia Clinical Trials is a trusted partner in clinical research, offering a comprehensive end-to-end solution for sponsors and participants alike. Established in 2011 by a team of visionary researchers at APC Microbiome Ireland, Atlantia was founded to address the urgent need for rigorous clinical trials in healthy populations, particularly for nutraceutical and dietary supplement companies navigating complex European health claim regulations.
Today, Atlantia Clinical Trials is a respected leader in clinical research, supporting sponsors in nutraceuticals, medical devices, pharmaceuticals, and cosmetics. With in-house clinics in Ireland and the U.S., including a state-of-the-art facility in Chicago, Atlantia conducts multicenter trials that deliver reliable data while reducing outsourcing costs.
Atlantia Clinical Trials is committed to transparency, precision, and integrity, ensuring sponsors achieve meaningful results and participants are supported throughout the clinical journey.